Articles From: Exelis Senior Vice President and Chief Financial Officer Peter Milligan to present at Cowen and Company 7th Annual Global Transportation and Aerospace and Defense Conference to Exelon Stresses Critical Role of Illinois’ Nuclear Energy Facilities in Meeting Carbon Reduction Goals


Exelis ( NYSE: XLS ) today announced that Senior Vice President and Chief Financial Officer Peter Milligan will present at the Cowen and Company 7 th Annual Global Transportation and Aerospace and Defense Conference on Thursday, Sept.
Sign-up for Exelis Senior Vice President and Chief Financial Officer Peter Milligan to present at Cowen and Company 7th Annual Global Transportation and Aerospace and Defense Conference investment picks
Exelis ( NYSE: XLS ) today announced that Senior Vice President and Chief Financial Officer Peter Milligan will present at the Gabelli 20 th Annual Aircraft and Supplier Conference in New York City on Tuesday, Sept.
Sign-up for Exelis Senior Vice President and Chief Financial Officer Peter Milligan to present at the Gabelli 20th Annual Aircraft and Supplier Conference investment picks
The U.S. Army Contracting Command has awarded Exelis (NYSE: XLS) a task order to deliver a limited quantity of SideHat ® SRW (Solidier Radio Waveform) Applique radios for evaluation.
Sign-up for Exelis SideHat radio to be tested by US Army investment picks
Exelis (NYSE: XLS ) today completed the previously announced separation of its former Mission Systems government services business into a new independent, publicly traded company, Vectrus, Inc. The spin-off has been structured to qualify as a tax-free distribution to Exelis shareholders for U.S. federal tax purposes, except for cash received in lieu of fractional shares.
Sign-up for Exelis successfully completes spin-off of Vectrus, Inc. investment picks
Signal Sentry™ 1000 , an Exelis ( NYSE: XLS ) product that detects and locates GPS interference sources, was deployed and tested during GPS jamming trials that occurred at Sennybridge, United Kingdom, last month.
Sign-up for Exelis successfully tests GPS threat detection product investment picks
Exelis ( NYSE: XLS ) will announce its 2014 third-quarter financial results at 6:30 a.m. EDT Friday, Oct.
Sign-up for Exelis to announce 2014 third-quarter financial results Oct. 31 investment picks
Exelis ( NYSE: XLS ) will exhibit at the Africa Aerospace and Defense 2014 tradeshow at Waterkloof Air Force Base in Tshwane, South Africa, Sept.
Sign-up for Exelis to demonstrate advanced air traffic management radar capability at Africa Aerospace and Defense 2014 investment picks
Exelis (NYSE: XLS) will showcase a variety of its leading defense and information solutions at the 2014 Association of the United States Army (AUSA) Annual Meeting and Exposition in Washington, District of Columbia, Oct.
Sign-up for Exelis to display ready-now affordable solutions and new technologies for the U.S. Army and international customers at 2014 AUSA Annual Meeting investment picks
Exelis ( NYSE: XLS ) will host an investor and analyst event Nov.
Sign-up for Exelis to hold investor and analyst event Nov. 4 investment picks
Exelis ( NYSE: XLS ) will debut Disruptor SRx™ , an adaptive, multifunctional electronic warfare (EW) capability during the Association of Old Crows (AOC) International Symposium and Convention at the Marriott Wardman Park Hotel in Washington, District of Columbia, Oct.
Sign-up for Exelis to Launch Next-Generation Electronic Warfare Capability at AOC Annual Symposium investment picks
Exelis ( NYSE: XLS ) will highlight its industry-leading defense and information technology solutions at the 2014 U.S. National Guard Association Conference & Exhibition in Chicago Aug.
Sign-up for Exelis to showcase leading capabilities at the 2014 U.S. National Guard Association Conference & Exhibition investment picks
Exelis ( NYSE: XLS ) has signed a teaming agreement with Airbus Group to provide advanced missile warning capabilities for U.S. and international F-16 Fighting Falcon aircraft.
Sign-up for Exelis, Airbus partner to provide missile warning capabilities for US and international F-16 aircraft investment picks
Exelixis, Inc. (NASDAQ:EXEL) today announced that cobimetinib, an Exelixis-discovered compound, will be the subject of a clinical data presentation at the European Society for Medical Oncology (ESMO) 2014 Congress.
Sign-up for Exelixis Announces Cobimetinib Phase 3 coBRIM Results to Be Presented at ESMO 2014 Congress investment picks
Exelixis Inc. (NASDAQ:EXEL) today announced the positive results from coBRIM, the phase 3 pivotal trial conducted by Exelixis’ collaborator Genentech, a member of the Roche Group, evaluating cobimetinib, a specific MEK inhibitor discovered by Exelixis, in combination with vemurafenib in previously untreated patients with unresectable locally advanced or metastatic melanoma harboring a BRAF V600 mutation.
Sign-up for Exelixis Announces Positive Results from Phase 3 Pivotal Trial of Cobimetinib in Combination with Vemurafenib in Patients with BRAF V600 Mutation-Positive Advanced Melanoma investment picks
Exelixis, Inc. (NASDAQ:EXEL) today announced positive top-line results from a randomized phase 2 trial of cabozantinib and erlotinib alone or in combination as second- or third-line therapy in patients with stage IV EGFR wild-type non-small cell lung cancer (NSCLC). This trial (Study E1512) is sponsored by the U.S. National Cancer Institute (NCI) through a Cooperative Research and Development Agreement between the Cancer Therapy Evaluation Program (CTEP), Division of Cancer Treatment and Diagnosis, NCI and Exelixis.
Sign-up for Exelixis Announces Positive Top-Line Results From a Phase 2 Trial of Cabozantinib and Erlotinib in Patients With EGFR Wild-Type Non-Small Cell Lung Cancer investment picks
Exelixis, Inc. (NASDAQ:EXEL) today announced top-line results from the final analysis of COMET-1, the phase 3 pivotal trial of cabozantinib in men with metastatic castration-resistant prostate cancer (mCRPC) whose disease progressed after treatment with docetaxel as well as abiraterone and/or enzalutamide.
Sign-up for Exelixis Announces Results from the COMET-1 Phase 3 Pivotal Trial of Cabozantinib in Men with Metastatic Castration-Resistant Prostate Cancer investment picks
Exelixis, Inc. (Nasdaq:EXEL) today reported financial results for the third quarter of 2014 and provided an update on its progress toward delivering upon its key corporate objectives and clinical development milestones.
Sign-up for Exelixis Announces Third Quarter 2014 Financial Results and Provides Corporate Update investment picks
Exelixis, Inc. (NASDAQ:EXEL) today announced that the enrollment target of 650 patients has been reached for METEOR, the company’s phase 3 pivotal trial of cabozantinib in patients with metastatic renal cell carcinoma (RCC) who have experienced disease progression following treatment with at least one VEGFR tyrosine kinase inhibitor (TKI). Top-line efficacy and safety data from METEOR are now expected in the second quarter of 2015.
Sign-up for Exelixis Completes Enrollment of the METEOR Phase 3 Pivotal Trial of Cabozantinib in Metastatic Renal Cell Carcinoma investment picks
Exelixis, Inc. (NASDAQ: EXEL) today announced that Michael M.
Sign-up for Exelixis to Present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 9 investment picks
Exelixis, Inc. (NASDAQ:EXEL) announced today that its third quarter 2014 financial results will be released on Tuesday, November 4, 2014 after the markets close.
Sign-up for Exelixis to Release Third Quarter 2014 Financial Results on Tuesday, November 4, 2014 investment picks
Exelon Corporation (NYSE:EXC) and Pepco Holdings Inc. (NYSE:POM) today filed an application seeking approval of their proposed merger ( click here for filing ) with the Maryland Public Service Commission.
Sign-up for Exelon and Pepco Holdings File for Merger Approval With Maryland Public Service Commission investment picks
Exelon Corporation (NYSE: EXC) announced third quarter 2014 consolidated earnings as follows: Third Quarter “Exelon achieved earnings above our guidance range this quarter, with strong performance from both our utility and generation businesses,” said Christopher M.
Sign-up for Exelon Announces Third Quarter 2014 Results investment picks
2014/10/21
The Board of Directors of Exelon Corporation declared a regular quarterly dividend of $0.31 per share on Exelon’s common stock.
Sign-up for Exelon Corporation Declares Dividend investment picks
2014/10/8
More than 150 minority- and women-owned business leaders joined an event yesterday to learn more about Exelon’s strategy to increase its spending with diverse suppliers.
Sign-up for Exelon Executives Build Connections with D.C.-Area Minority- and Women-Owned Business Leaders investment picks
KENNETT SQUARE, Pa.
Sign-up for Exelon Generation To Build Two New Natural Gas Units In Texas investment picks
2014/11/5
Emerging technologies from drone robotics to smart home devices were on display Tuesday at Exelon Corporation’s third Innovation Expo, an event aimed at bringing employees and outside experts together to explore how to apply creative solutions to complicated business challenges.
Sign-up for Exelon Hosts Innovation Expo Focused on the “Internet of Things” investment picks
2014/9/29
The Lone Star State has a new reason to claim that “everything’s bigger in Texas.” In a more than half-a-billion-dollar order, Exelon, one of the largest competitive U.S. power generators, turned to GE (NYSE:GE) to purchase four 7HA gas turbines, two D600 steam turbines, six generators and a contractual service agreement for the Wolf Hollow and Colorado Bend gas combined-cycle projects.
Sign-up for Exelon Orders GE’s H-Class Gas Turbines—the World’s Largest and Most Efficient—for U.S. Combined-Cycle Power Projects investment picks
Exelon has been named to two independent indexes – the Dow Jones Sustainability Indices (DJSI) and CDP – in recognition of its corporate sustainability performance and reporting of climate-related information.
Sign-up for Exelon Recognized for Corporate Sustainability Performance and Reporting by Two Global Authorities investment picks
2014/10/23
Exelon arranged $123 million in credit lines with 31 community and minority-owned banks in Illinois, Pennsylvania, Maryland and New Jersey, reinforcing the company’s commitment to invest in the diverse communities it serves.
Sign-up for Exelon Secures Credit Agreements with 31 Minority and Community Banks in Program’s Twelfth Year investment picks
2014/9/23
To meet forthcoming carbon emissions reduction targets, Illinois must preserve its existing nuclear energy facilities, Exelon Senior Vice President of Federal Regulatory Affairs and Wholesale Market Policy Kathleen Barrón said today at a policy session convened by the Illinois Commerce Commission.
Sign-up for Exelon Stresses Critical Role of Illinois’ Nuclear Energy Facilities in Meeting Carbon Reduction Goals investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Exelis Senior Vice President and Chief Financial Officer Peter Milligan to present at Cowen and Company 7th Annual Global Transportation and Aerospace and Defense Conference to Exelon Stresses Critical Role of Illinois’ Nuclear Energy Facilities in Meeting Carbon Reduction Goals
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent